Display options
Share it on

J Funct Biomater. 2021 Feb 01;12(1). doi: 10.3390/jfb12010009.

Drastic Reduction of Bacterial, Fungal and Viral Pathogen Titers by Cuprous Oxide Impregnated Medical Textiles.

Journal of functional biomaterials

Gadi Borkow, Rachel Salvatori, Vikram K Kanmukhla

Affiliations

  1. Cupron Scientific Ltd., Hasadnaot 10, Herzliya 4672837, Israel.
  2. Cupron Inc., 4329 November Avenue, Richmond, VA 23231, USA.

PMID: 33535519 PMCID: PMC7930948 DOI: 10.3390/jfb12010009

Abstract

Hospital patients and personnel are at risk of nosocomial viral infections, as clearly manifested during the COVID-19 pandemic. Transmission of respiratory viral pathogens can occur through contaminated surfaces, including from medical textiles. Copper has potent biocidal properties, and cuprous oxide impregnated medical textiles (CMT) reduce hospital-acquired bacterial infections. In the current study we confirm the antimicrobial properties of CMT and determine their capacity to reduce infectious titres of human coronavirus (HCoV-229E) in an independent laboratory. The antibacterial and antiviral activities of the CMT were determined according to AATCC TM100-2019 and ISO 18184:2019 standards, respectively. The CMT reduced by 4 logs the viable titers of MRSA,

Keywords: coronavirus; cuprous oxide; hospital acquired infections; medical textiles; pathogens

References

  1. mBio. 2015 Nov 10;6(6):e01697-15 - PubMed
  2. FASEB J. 2004 Nov;18(14):1728-30 - PubMed
  3. Am J Infect Control. 2016 Dec 1;44(12):1565-1571 - PubMed
  4. J Hosp Infect. 2020 Mar;104(3):246-251 - PubMed
  5. Microbes Environ. 2015;30(2):140-4 - PubMed
  6. Curr Med Chem. 2005;12(18):2163-75 - PubMed
  7. Astrobiology. 2017 Dec;17(12):1183-1191 - PubMed
  8. J Hosp Infect. 2016 Mar;92(3):235-50 - PubMed
  9. Ecotoxicol Environ Saf. 2021 Jan 15;208:111438 - PubMed
  10. N Engl J Med. 2020 Mar 5;382(10):970-971 - PubMed
  11. AMB Express. 2020 May 15;10(1):92 - PubMed
  12. ACS Appl Mater Interfaces. 2020 Aug 5;12(31):34723-34727 - PubMed
  13. J Hazard Mater. 2016 Jul 15;312:1-7 - PubMed
  14. J Appl Microbiol. 2012 Mar;112(3):614-21 - PubMed
  15. Med Hypotheses. 2008;70(5):990-4 - PubMed
  16. Antimicrob Agents Chemother. 2008 Feb;52(2):518-25 - PubMed
  17. Antimicrob Agents Chemother. 2007 Jul;51(7):2605-7 - PubMed
  18. Curr Microbiol. 2020 Mar;77(3):361-368 - PubMed
  19. Langmuir. 2013 Dec 31;29(52):16160-6 - PubMed
  20. FEMS Microbiol Rev. 2012 Jul;36(4):786-814 - PubMed
  21. J Aerosol Sci. 2018 Mar;117:200-211 - PubMed
  22. Lancet Microbe. 2020 May;1(1):e10 - PubMed
  23. J Hosp Infect. 2018 Nov;100(3):e130-e134 - PubMed
  24. Viruses. 2020 Mar 27;12(4): - PubMed
  25. PLoS One. 2010 Jun 25;5(6):e11295 - PubMed
  26. Wounds. 2010 Dec;22(12):301-10 - PubMed
  27. J Hosp Infect. 2008 May;69(1):8-23 - PubMed
  28. MMWR Morb Mortal Wkly Rep. 2020 Apr 17;69(15):472-476 - PubMed
  29. PeerJ. 2020 Aug 25;8:e9790 - PubMed
  30. N Engl J Med. 2020 Apr 16;382(16):1564-1567 - PubMed
  31. Int J Infect Dis. 2014 Jul;24:23-9 - PubMed
  32. Am J Infect Control. 2017 Apr 1;45(4):401-403 - PubMed
  33. Infect Disord Drug Targets. 2020 Nov 15;: - PubMed

Publication Types